Xenco Medical

Executive Summary

Xenco Medical is a privately held medical technology company headquartered in San Diego, CA, focused on disrupting traditional surgical implant systems through its proprietary SETx Technology. The company's single-use, composite polymer devices eliminate the expensive, cumbersome, and inefficient processes associated with conventional implants, aiming to create a safer surgical environment. Founded in 2014, Xenco Medical leverages advanced materials science and mechanical design to offer innovative solutions that reduce infection risk and streamline surgical workflows. While the company remains in a relatively early stage without disclosed funding or revenue, its novel approach addresses significant pain points in the $50+ billion global orthopedic and surgical device market. Xenco Medical's technology has the potential to gain traction if clinical validations and regulatory clearances are achieved, positioning it as a disruptive player in the shift toward single-use, high-performance medical devices.

Upcoming Catalysts (preview)

• Q2 2025FDA 510(k) Clearance for New Composite Polymer Implant65% success
• Q3 2025Strategic Partnership or Distribution Agreement with Major Surgical Device Distributor45% success
• Q4 2025Clinical Study Publication Demonstrating Safety and Efficacy of SETx Technology55% success